Outsourcing on the rise, despite supply chain risks; Lonza upbeat;

> Contract manufacturer Lonza says business is good--so good that it confirms "an intact trend toward outsourcing." Article

> Pharmaceutical outsourcing is creating a risky supply chain environment. Story

> Next week, ISPE will release GAMP Good Practice Guide: Calibration Management, Second Edition. ISPE release

> Acsis, Cognex, Nosco and Omega Design have teamed to help drugmakers wrestling with upcoming federal and state ePedigree and serialization mandates. Release

> Good to know: Chief legal officers at pharma manufacturing companies boasted the highest median salary last year--$355,000--among all industries. Article

> Layoffs in the pharmaceutical industry dropped to 1,900 in October, way down from September's 6,069. Item

> Hard times await drug counterfeiters in Nigeria with the reactivation of the federal task force on counterfeit and fake drugs. News

> Vietnamese doctors and patients alike prefer imported drugs over cheaper domestic ones. Report

> Use a risk-based approach in selecting API manufacturers and suppliers; conduct audits. Article

> Potentially toxic belladonna in some Hyland's Teething Tablets has led to a recall. FDA update

> Joyce Chiu, a 20-year veteran of the chemical and life sciences industries, has earned  the ISPE Certified Pharmaceutical Industry Professional credential. ISPE release

Suggested Articles

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.